In Silico World
Join the community
Experts from all over Europe working towards a wider use of In Silico Trials
Lowering the barriers to a universal adoption of In Silico Trials
Our mission and vision
The In Silico World project aims at accelerating the uptake of modelling and simulation technologies used for the development and regulatory assessment of medicines and medical devices, by lowering seven identified barriers: development, validation, accreditation, optimisation, exploitation, information, and training.
Our mission
Lowering the barriers to a universal adoption of In Silico Trials
Our vision
A future where medical products, thanks to the use of modelling and simulation, are developed much faster and with the highest possible safety standards
Who can benefit?
Researchers
Access resources that help accelerating the adoption of the In Silico Trials solutions you developed: connect with your community of peers
Discover more →Industry
Learn how adopting In Silico Trials for the assessment of new medical products can offer your company a substantial competitive advantage
Collaborate →Clinicians
Discover what is In Silico medicine, its strengths and weaknesses and how it can be used in computer simulations for patient-specific clinical decision support
Discover more →Patients and Public
Learn how In Silico Trials can transform healthcare, by providing better, safer and cheaper medical products
Discover more →What's new in In Silico World?
Read all postsIn Silico World releases its first data collection: HFValid
Read about our latest milestone in validation data for heart failure modelling.
Read →Consortium - Meet the people
The In Silico World consortium sees the participation of world-class leaders in technological research, clinical research, and industrial innovation in the field of In Silico Trials from six European countries. We count on a total of more than 100 professionals from 17 partner institutions including universities, companies, research hospitals, an international research centre, a non-governmental organisation and a standardisation body.
Alma Mater Studiorum - Università di Bologna
Most activities assigned to partner UNIBO in the ISW project will be responsibility of the In Silico Medicine Group led by Prof Marco Viceconti, based at the Department of Industrial Engineering.
Universiteit van Amsterdam
The Computational Science Lab of the faculty of Science aims to describe and understand how complex systems in nature and society process information.
Technische Universiteit Eindhoven
Eindhoven University of Technology is a research university specializing in engineering science and technology, leading data management aspects.
Università degli Studi di Catania
The Computational Systems Biomedicine Research Group - COMBINE drives research in applying computational methodologies to the field of biomedicine.
Want to get in touch?
Would you like to know more about In Silico World? Do you have any questions for us?
Connect to the In Silico World Community and join the movement towards safer, faster medical product development.